CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $65.98M, above the global median of $18.73M
- FinancialsAltman Z-Score 4.86: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.48%Below 5Y avg (2.63%)
Annual Rate
CNY 0.22Paid annual
Payout Ratio
34.8%Sustainable
Payback Period
67.3 yr
Last Ex-Dividend
Sep 16, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.61BCNY987.78M · vs all stocks (USD)
Trailing P/E
14.46xRevenue (TTM)
3.40BCNY507.44M · vs all stocks (USD)
Profit Margin
13.44%Beta
0.1510xvs all stocks
52-Week Change
-27.40%vs all stocks
Market Capitalization
6.61BCNY987.78M · vs all stocks (USD)
Enterprise Value
2.59BCNY386.38M · vs all stocks (USD)
Trailing P/E
14.46xForward P/E
10.11xPrice to Sales (TTM)
1.93xPrice to Book (MRQ)
1.03xEnterprise to Revenue
0.7610xEnterprise to EBITDA
5.96xGross Margin
51.14%Profit Margin
13.44%Operating Margin
-0.88%Return on Assets (TTM)
1.83%Return on Equity (TTM)
7.35%Revenue (TTM)
3.40BCNY507.44M · vs all stocks (USD)
Revenue per Share (TTM)
7.45CNYUpdated Sep 22, 2026Quarterly Revenue Growth
2.80%Gross Profit (TTM)
1.67BCNY248.75M · vs all stocks (USD)
EBITDA (TTM)
437.97MCNY65.40M · vs all stocks (USD)
Net Income (TTM)
456.53MCNY68.17M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
56.20%Operating Cash Flow (TTM)
540.15MCNY80.66M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
441.86MCNY65.98M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.2160CNYUpdated Sep 22, 2026Trailing Annual Dividend Yield
1.48%vs all stocks
5-Year Average Dividend Yield
2.63%vs all stocks
Payout Ratio
34.80%Minority Interest (Equity)
39.52MCNYFY2025 · Dec 31, 2025Revenue
3.44BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
1.66BCNYFY2025 · Dec 31, 2025Gross Profit
1.79BCNYFY2025 · Dec 31, 2025Operating Income
376.64MCNY56.24M · vs all stocks (USD)
Pre-tax Income
496.19MCNYFY2025 · Dec 31, 2025Income Tax Expense
70.58MCNYFY2025 · Dec 31, 2025Net Income
425.62MCNYFY2025 · Dec 31, 2025EBIT
497.53MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
729.04MCNYFY2025 · Dec 31, 2025Research & Development
285.78MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
906.84MCNYFY2025 · Dec 31, 2025Other Operating Expenses
62.86MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
32.62MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.34MCNYFY2025 · Dec 31, 2025Net Income from Continuing Operations
425.62MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.37MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
511.01MCNYFY2025 · Dec 31, 2025Free Cash Flow
449.60MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.18BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
425.62MCNYFY2025 · Dec 31, 2025Other Non-cash Items
2.60MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-102.24MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
185.03MCNYFY2025 · Dec 31, 2025Capital Expenditures
-61.41MCNYFY2025 · Dec 31, 2025Sale of Investments
153.12MCNYFY2025 · Dec 31, 2025Other Investing Activity
-265.53MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-173.82MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
15.34MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-70.81MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-182.92MCNYFY2025 · Dec 31, 2025Other Financing Charges
8.67MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-229.72MCNYFY2025 · Dec 31, 2025Shares Outstanding
452.75MSharesUpdated Sep 22, 2026Float Shares
205.06MSharesUpdated Sep 22, 2026% Held by Insiders
53.72%vs all stocks
% Held by Institutions
1.68%vs all stocks
Total Cash (MRQ)
4.03BCNY602.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.91CNYUpdated Sep 22, 2026Total Debt (MRQ)
32.84MCNY4.90M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0051xCurrent Ratio (MRQ)
4.53xBook Value per Share (MRQ)
14.10CNYUpdated Sep 22, 2026Total Assets
7.60BCNY1.13B · vs all stocks (USD)
Total Current Assets
5.21BCNYFY2025 · Dec 31, 2025Total Liabilities
1.37BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.39BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
142.98MCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.22BCNYFY2025 · Dec 31, 2025Cash
1.21BCNYFY2025 · Dec 31, 2025Cash Equivalents
1.79MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.21BCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.73BCNYFY2025 · Dec 31, 2025Accounts Receivable
542.13MCNYFY2025 · Dec 31, 2025Inventory
623.69MCNYFY2025 · Dec 31, 2025Accounts Payable
620.31MCNYFY2025 · Dec 31, 2025Short-term Debt
14.12MCNYFY2025 · Dec 31, 2025Other Current Liabilities
193.39MCNYFY2025 · Dec 31, 2025Long-term Debt
29.41MCNYFY2025 · Dec 31, 2025Common Stock (Book)
452.75MCNYFY2025 · Dec 31, 2025Retained Earnings
3.58BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.23BCNY930.43M · vs all stocks (USD)
52-Week Low
12.13CNYUpdated Sep 22, 202652-Week High
24.85CNYUpdated Sep 22, 202652-Week Change
-27.40%vs all stocks
Beta
0.1510xvs all stocks
50-Day MA
14.53CNYUpdated Sep 22, 2026200-Day MA
15.72CNYUpdated Sep 22, 2026Avg 10-Day Volume
5.25MSharesUpdated Sep 22, 2026Avg 30-Day Volume
10.11MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
1.00CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.86: safe zoneNotable
Altman Z-Score: 4.86
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $65.98M, above the global median of $18.73MNotable
Levered free cash flow (USD): 65,982,332.587Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Edan Instruments Inc.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Er-Kang Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Northeast Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Vor Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Jinghua Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Wuhan Huakang Century Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Ausun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Janux Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Procept BioRobotics Corporation
Tier 1ProductionApproval-Gated PipelineRule
Corvus Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Daoming Optics & Chemical Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Northking Information Technology Inc.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Humedix Co., Ltd.
1 interpretationMRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities